Alpha lipoic acid in burning mouth syndrome - A randomized double-blind placebo-controlled trial

Journal of Oral Pathology and Medicine

Volumn 38, Issue 3, 2009, Pages 254-261

  Cavalcanti, Desirée Rosa ^a,b   Da Silveira, Fernando Ricardo Xavier ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UMC Mogi das Cruzes   (Brazil)

Author keywords

Alpha lipoic acid; Burning mouth syndrome

Indexed keywords

PLACEBO; THIOCTIC ACID;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BURNING MOUTH SYNDROME; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUNGER; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIOXIDANTS; BURNING MOUTH SYNDROME; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; THIOCTIC ACID;

EID: 61349135806     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00735.x     Document Type: Article

References (44)

1. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002 65 : 615 20.
2. Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999 28 : 350 4.
3. Gorsky M, Silverman S, Chinn H. Clinical characteristics and management outcome in the burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1991 72 : 192 5.
4. Van Der Wäal I. The burning mouth syndrome. Copenhagen : Munksgaard, 1990.
5. Lamey PJ. Burning mouth syndrome: approach to successful management. Dent Update 1998 25 : 298 300.
6. Ship JA, Grushka M, Lipton JA, Mott AE, Sessle BJ, Dionne RA. Burning mouth syndrome: an update. J Am Dent Assoc 1995 126 : 842 53.
7. Grushka M. Clinical features of burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987 63 : 30 6.
8. Cavalcanti DR, Birman EG, Migliari DA, Silveira FR. Burning mouth syndrome: clinical profile of Brazilian patients and oral carriage of Candida species. Braz Dent J 2007 18 : 341 5.
9. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome: differential diagnosis. Dermatol Ther 2002 15 : 287 91.
10. Tanaka M, Kitago H, Ogawa S, Tokunaga E, Ikeda M, Tomita H. Incidence and treatment of dysgeusia in patients with glossodynia. Acta Otolaryngol 2002 546 (Suppl. 142 5.
11. Van Der Plöeg HM, Van Der Wäll N, Eijkman MAJ, Van Der Wäll I. Psychological aspects of patiens with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987 63 : 664 8.
12. Hershkovich O, Nagler R. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Arch of Oral Biol 2004 49 : 515 22.
13. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome and other oral sensory disorders: a unifying hypothesis. Pain Res Manag 2003 8 : 133 5.
14. Gao S, Wang Y, Wang Z. Assessment of trigeminal somatosensory evoked potentials in burning mouth syndrome. Chin J Dent Res 2000 3 : 40 6.
15. Jääskeläinen SK, Forssel H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain 1997 73 : 455 60.
16. Jääskeläinen SK, Rinne Jo, Forssel H, et al. Role of dopaminergic system in chronic pain - a fluorodopa-PET study. Pain 2001 90 : 257 60.
17. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005 115 : 332 7.
18. Grushka M, Sessle BJ, Howley TP. Psychological assesssment of tactile, pain and thermal sensory functions in burning mouth syndrome. Pain 1987 28 : 169 84.
19. Formaker Bk, Frank ME. Taste function in patients with oral burning. Chem Senses 2000 25 : 575 81.
20. Ito M, Kurita K, Ito T, Arao M. Pain threshold and pain recovery after experimental stimulation in patients with burning mouth syndrome. Psychiatr Clin Neurosci 2002 56 : 161 8.
21. Hagelberg N, Forssell H, Rinne JO, et al. Striatal dopamine D1 end D2 receptors in burning mouth syndrome. Pain 2003 101 : 149 54.
22. Yilmaz Z, Renton T, Yiangou Y, et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007 14 : 864 71.
23. Grushka M, Epstein J, Mott A. An open-label, dose scalation pilot study of the effect of clonazepam in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998 86 : 557 61.
24. Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrassi A. Benzydamine hydrocloride oral rinse in management of Burning Mouth Syndrome. Oral Sur Oral Med Oral Pathol Oral Radiol Endod 1999 88 : 683 6.
25. Gremeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004 108 : 51 7.
26. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005 25 : CD002779.
27. Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003 26 : 770 6.
28. Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001 17 : 888 95.
29. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995 19 : 227 50.
30. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995 38 : 1425 33.
31. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999 22 : 1296 301.
32. Bilska A, Wlodek L. Lipoic acid - the drug of the future? Pharmacol Rep 2005 57 : 570 7.
33. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS): controlled open trial the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000 6 : 274 7.
34. Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002 31 : 267 9.
35. Femiano F, Gombos F, Scully C. Burxning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol 2004 18 : 676 8.
36. Femiano F, Gombos F, Scully C. Burning Mouth Syndrome (BMS): open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 2004 9 : 8 13.
37. Steele JC, Bruce AJ, Drage LA, Rogers RS. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth. Oral Dis 2008 14 529 32.
38. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recomendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 (Suppl. 1 S39.e1 13.
39. Grushka MW, Ching V, Polak S. Retrospective study: prevalence of geographic and fissured tongue in patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 : 789.
40. Hakeberg M, Bergren U, Häglin C, Ahlqwist M. Reported burning mouth symptoms among middle-aged and elderly women. Eur J Oral Sci 1997 105 : 539 43.
41. Femiano F, Lanza A, Buonaiuto C, et al. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008 105 : e22 7.
42. Llorca CS, Serra MPM, Silvestre FJ. Drug-induced burning mouth syndrome: a new etiological diagnosis. Med Oral Patol Oral Cir Bucal 2008 13 : e167 70.
43. Femiano F. Damage to taste system and oral pain: burning mouth syndrome. Minerva Stomatol 2004 53 : 471 8.
44. Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2008 doi : Epub ahead of print).